Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Completed · Phase 3

Conditions studied: Plaque Psoriasis

In brief

This study is to evaluate the safety and efficacy of a topical lotion when applied once daily to adult participants with moderate to severe plaque psoriasis (defined as an Investigator's Global Assessment \[IGA\] score of 3 or 4).

Key facts

Study ID

NCT02514577

Run by

Bausch Health Americas, Inc.

People needed

217

Starts

2015-11-07

Expected to finish

2017-05-01

Last updated by the study team

2020-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 11 — Hot Springs, Arkansas, United States
• Valeant Site 1 — Encinitas, California, United States
• Valeant Site 10 — Encino, California, United States
• Valeant Site 12 — Santa Rosa, California, United States
• Valeant Site 13 — Atlanta, Georgia, United States
• Valeant Site 7 — Boise, Idaho, United States
• Valeant Site 6 — Rockville, Maryland, United States
• Valeant Site 4 — Ann Arbor, Michigan, United States
• Valeant Site 8 — Clarkston, Michigan, United States
• Valeant Site 15 — Las Vegas, Nevada, United States
• Valeant Site 9 — Raleigh, North Carolina, United States
• Valeant Site 5 — Knoxville, Tennessee, United States
• Valeant Site 3 — Austin, Texas, United States
• Valeant Site 2 — San Antonio, Texas, United States
• Valeant Site 14 — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.